Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant collagen dressing for repair of facial skin barrier injury after cosmetic procedures
ChiCTR2400091943Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Jinan University
- Start
- Nov 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, single-blind trial of recombinant collagen in skin barrier injury (2 arms), sponsored by First Affiliated Hospital of Jinan University. Primary endpoint: Repair rate of skin barrier damage. Planned start Nov 2024; status: not yet recruiting.
02
Drugs
recombinant collagen
03
Conditions
skin barrier injury
Beyond the preview
Go deeper on ChiCTR2400091943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400091943.